Valneva Se(NASDAQ) VALN

Market Cap$676.09M

Since IPO (2021)-75%

5 Year-73%

1 Year-32%

1 Month+39%

$7.13

+26.20%

+1.48Today

After hours$6.99-$0.14 (-1.96%)

Valneva Se last closing stock price
Metric	Price	Date
Last close	USD 7.13	2026-08-14

Valneva Se stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+34.53%	USD 5.30	2026-08-07
1 month	+39.12%	USD 5.13	2026-07-15
3 month	+25.53%	USD 5.68	2026-05-15
Year to date	-19.16%	USD 8.82	2025-12-31
1 year	-31.9%	USD 10.47	2025-08-14
3 year	-46.07%	USD 13.22	2023-08-15
5 year	-73.24%	USD 26.65	2021-08-13
Since inception	-74.85%	USD 28.35	2021-05-06

Valneva Se Financials at a Glance

Market Cap

$676.09M

Revenue (TTM)

€143.51M

Net Income (TTM)

-€158.17M

EPS (TTM)

-$2.09

P/E Ratio

-3.81

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$7.13

Volume

2,882,842.3

Open

$7.00

Price

$7.13

Volume

2,882,842.3

Open

$7.00

Previous Close

$7.13

Daily Range

$6.83 - $7.31

52-Week Range

$4.75 - $12.25

Estimated Earnings Date

Nov 19, 2026

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$7.13

Volume

2,882,842.3

Open

$7.00

Previous Close

$7.13

Daily Range

$6.83 - $7.31

52-Week Range

$4.75 - $12.25

Estimated Earnings Date

Nov 19, 2026

VALN News

VALN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Valneva Se

Valneva SE is a specialty vaccine company focused on developing vaccines for infectious diseases with significant unmet needs. With its strong foundation in proprietary technologies and strategic collaborations, Valneva aims to swiftly address emerging health threats. The company is guided by a management team with extensive expertise in vaccine development and commercialization, driving its growth strategy centered on high-potential markets and innovative vaccines.

Products and Services

Prophylactic vaccines for infectious diseases such as Lyme disease and chikungunya.

Advanced clinical programs for emerging health threats.

Strategic partnerships with global health organizations and biotech firms.

What Makes Valneva SE Special

Valneva SE distinguishes itself with its focused approach to vaccine development for diseases with unmet needs, leveraging proprietary technologies and strategic partnerships. Its capability to quickly address health threats and expand its R&D pipeline through collaborations enhances its market position.

Five Things You Need to Know

Valneva SE specializes in prophylactic vaccines targeting unmet medical needs.

The company utilizes proprietary technologies and strategic collaborations to enhance development and market access.

Valneva has ongoing clinical programs for vaccines against Lyme disease and chikungunya.

The management team has a proven track record in vaccine development and navigating regulatory landscapes.

Strategic alliances provide financial support and market access, promoting innovation and expansion.

AI Generated • Apr 16, 2026

Industry

Biotechnology

Sector

Health Care

Employees

634

CEO

Thomas Lingelbach, PhD

Website

www.valneva.com

Headquarters

Saint-Herblain, GE 44800, FR

VALN Financials

Key Financial Metrics (TTM)

Gross Margin

16.40%

Operating Margin

-86.68%

Net Income Margin

-110.29%

Return on Equity

-152.15%

Return on Capital

-26.05%

Return on Assets

-40.60%

Earnings Yield

-26.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$676.09M

Shares Outstanding

94.82M

Volume

2.88M

Avg. Volume

74.76K

Financials (TTM)

Gross Profit

€23.47M

Operating Income

-€116.14M

EBITDA

-€94.30M

Operating Cash Flow

-€83.15M

Capital Expenditure

-€2.52M

Free Cash Flow

-€85.67M

Cash & ST Invst.

€121.48M

Total Debt

€210.14M

Valneva Se Performance Analysis

Valneva Se annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 379,720,174	-7.7%
2023	2023-12-31	EUR 166,181,523	-56.2%
2024	2024-12-31	EUR 183,432,037	10.4%
2025	2025-12-31	EUR 197,116,296	7.5%

Valneva Se sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-39.1%
Q4	2025-12-31	62.2%
Q1	2026-03-31	-35.2%
Q2	2026-06-30	14.9%

Valneva Se annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -2.61	46.7%
2023	2023-12-31	EUR -1.58	-39.3%
2024	2024-12-31	EUR -0.18	-88.5%
2025	2025-12-31	EUR -1.55	750.4%

Valneva Se sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-245.3%
Q4	2025-12-31	-11.5%
Q1	2026-03-31	34.5%
Q2	2026-06-30	10.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€35.52M

-26.5%

Gross Profit

€1.63M

-93.3%

Gross Margin

4.58%

N/A

Market Cap

$676.09M

N/A

Market Cap/Employee

$1.00M

N/A

Employees

674

N/A

Net Income

-€31.72M

-173.8%

EBITDA

-€22.91M

-269.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€121.48M

-24.7%

Total Debt

€210.14M

+6.7%

Accounts Receivable

€16.33M

-32.3%

Inventory

€48.14M

-22.0%

Long Term Debt

€189.00M

+27.5%

Short Term Debt

€21.15M

-56.5%

Return on Assets

-40.60%

N/A

Return on Invested Capital

-43.48%

N/A

Free Cash Flow

-€18.81M

-364.3%

Operating Cash Flow

-€18.46M

-560.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ARVNArvinas, Inc.

ARVNArvinas, Inc.$8.97-0.44%

DNAGinkgo Bioworks Holdings, Inc.

DNAGinkgo Bioworks Holdings, Inc.$6.79-6.22%

GERNGeron Corporation

GERNGeron Corporation$1.47-4.23%

MGTXMeiraGTx Holdings plc

MGTXMeiraGTx Holdings plc$13.52+6.71%

REPLReplimune Group, Inc.

REPLReplimune Group, Inc.$14.97-1.45%

AVBPArriVent BioPharma, Inc.

AVBPArriVent BioPharma, Inc.$29.51-1.63%

DAWNDay One Biopharmaceuticals, Inc.

DAWNDay One Biopharmaceuticals, Inc.$21.53+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.23+0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.76+0.01%

ONDSOndas

ONDSOndas$9.24+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$140.00-0.01%

INTCIntel

INTCIntel$102.50-0.02%

NVDANvidia

NVDANvidia$225.16-0.00%

NOKNokia

NOKNokia$10.76+0.02%

Questions About VALN

What is the current price of Valneva Se?

Valneva Se is trading at $7.13 per share.

What is the 52-week range for Valneva Se?

Over the past 52 weeks, Valneva Se has traded between $4.75 and $12.25.

How much debt does Valneva Se have?

As of the most recent reporting period, Valneva Se reported total debt of €240.36M.

How much cash does Valneva Se have on hand?

Valneva Se reported €138.94M in cash and cash equivalents in its most recent financial results.

What is Valneva Se’s dividend yield?

Valneva Se does not currently have a dividend yield.

Valneva Se(NASDAQ) VALN

Valneva Se Financials at a Glance

VALN News

Is This New Data on Valneva's Less-Effective Booster Concerning?

2 Stocks That Could Soar With the Emergence of the Omicron Variant

These 2 Nasdaq Biotechs Are Making Huge Premarket Moves Monday

VALN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Valneva Se

Products and Services

What Makes Valneva SE Special

Five Things You Need to Know

VALN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Valneva Se Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VALN

What is the current price of Valneva Se?

What is the 52-week range for Valneva Se?

How much debt does Valneva Se have?

How much cash does Valneva Se have on hand?

What is Valneva Se’s dividend yield?

Premium Investing Services